Aug Pharma System Sustainability Profile
Aug Pharma System, headquartered in Egypt, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative healthcare solutions. Founded in 2005, the company has established a strong presence across the Middle East and North Africa, focusing on areas such as prescription medications, over-the-counter products, and advanced therapeutic solutions. With a commitment to quality and efficacy, Aug Pharma System offers a diverse portfolio of core products that cater to various medical needs, setting itself apart through rigorous research and development. The company has achieved significant milestones, including strategic partnerships and a growing market share, positioning itself as a trusted name in the pharmaceutical landscape. Through its dedication to improving patient outcomes, Aug Pharma System continues to make strides in enhancing healthcare accessibility and effectiveness.
DitchCarbon Score
How does Aug Pharma System's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aug Pharma System's score of 20 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aug Pharma System's reported carbon emissions
Aug Pharma System, headquartered in Egypt (EG), currently does not report any carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established specific reduction targets or climate pledges, indicating a lack of formal commitments to address carbon emissions at this time. As a result, there are no details regarding the scope of emissions (Scope 1, 2, or 3) or any significant achievements in emissions reduction. Without concrete data or commitments, it is challenging to assess Aug Pharma System's position in the context of industry climate initiatives. The absence of emissions data and reduction initiatives suggests that Aug Pharma System may need to enhance its focus on sustainability and climate action to align with industry standards and expectations.
How Carbon Intensive is Aug Pharma System's Industry?
How Carbon Intensive is Aug Pharma System's Location?
Aug Pharma System's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aug Pharma System has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
